The artificial intelligence trade is getting tested by the bears. But this AI stock is finding support as it flirts with an ...

Insurance leader Neptune stock breaks out above its latest buy point amid a volatile stock market environment.

Spyre Therapeutics is building a long-acting antibody platform across IBD and rheumatology. Read why I only rate SYRE stock a ...

Allegro MicroSystems, Inc. (NASDAQ:ALGM) is one of the High Growth Semiconductor Stocks to Buy Now. Allegro MicroSystems, Inc ...

Maybe you have ordered an at-home microbiome test and waited on a report full of unfamiliar bacteria names. Maybe you are ...

Alphabet shares fell as investors worried about Google’s AI talent losses. Noam Shazeer left for OpenAI, while John Jumper left DeepMind for Anthropic. Heavy AI spending is raising margin concerns as ...

“Supporting initiatives like the Take Steps Walk reflects our dedication to making a positive impact beyond the workplace,” said Barry Lynch, Managing Partner of IDI Consulting. “We’re honored to ...

Discover a proven method to pick high-growth dividend stocks using dividend growth, quality scores and momentum.

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.

Scientists have gained major new insights into inflammatory bowel disease (IBD), a term that includes the gastrointestinal disorders Crohn’s disease and ulcerative colitis. IBD is thought to impact ...